Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis

Systemic sclerosis (SSc) is an intractable autoimmune disease characterized by vasculopathy and organ fibrosis. Autologous hematopoietic stem cell transplantation (AHSCT) should be considered for the treatment of selected patients with rapid progressive SSc at high risk of organ failure. It, however...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Pers Med
Autori principali: Gressenberger, Paul, Jud, Philipp, Kovacs, Gabor, Kreuzer, Sonja, Brezinsek, Hans-Peter, Guetl, Katharina, Muster, Viktoria, Kolesnik, Ewald, Schmidt, Albrecht, Odler, Balazs, Adelsmayr, Gabriel, Neumeister, Peter, Brcic, Luka, Zenz, Sabine, Weber, Kurt, Gary, Thomas, Brodmann, Marianne, Graninger, Winfried B., Moazedi-Fürst, Florentine C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2021
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8305780/
https://ncbi.nlm.nih.gov/pubmed/34201939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11070600
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi